-E1-E2-p7-NS2/3-NS4A-NS4B-NS5A-NS5B (Rümenapf et al., 1993; Tautz et al., 1997; Collet et al., 1988) .
Based on the nucleotide sequence of 5'-UTR, the two genotypes BVDV-1 and BVDV-2 are recognized (Ridpath et al., 1994; Tajima et al., 2001; Vilcek et al., 2001; Couvreur et al., 2002) . BVDV-1 can be divided into at least 11 genetic groups (Vilcek et al., 2001; Jackova et al., 2008) . BVDV-2 isolates were classified into two subtypes termed as BVDV-2a and BVDV-2b (Flores et al., 2002) . Initially, BVDV-2 viruses were identified in severe outbreaks of acute bovine viral diarrhea disease in North America in late 1980s (Perdrizet et al., 1987; Corapi et al., 1989) . Now, BVDV-2 infection is widely distributed in Asia, namely in Japan (Nagai et al., 2001) , Korea (Kim et al., 2006) , and India (Mishra et al., 2008) . Recently, a BVDV-2 strain isolated from cattle in China has been reported (Zhu et al., 2009 In November 2004, the tissue samples including the spleen, lymph node, liver, and kidney were collected from a 3-months old calf in small farm in Xinjiang province. The calf showed clinical symptoms of pestivirus infection such as severe diarrhea and conjunctival hemorrhage. A viral isolate XJ-04 was isolated from the collected samples in our laboratory and preliminarily identified as BVDV-2. The isolate was able to produce a cytopathic effect in the culture of Madin-Darby bovine kidney (MDBK) cells (unpublished data). Here, we report the complete genomic sequence of the isolate XJ-04 and compare it with the genomic sequences of other BVDV strains.
Seventeen pairs of primers named alphabetically from A to Q were designed, based on the information of 6 fulllength genomic sequences of BVDV-2 available from GenBank (Acc. Nos. U18059, AF502399, AY149215, AF0 02227, AF145967, and AY149216). The primers were used to amplify 17 DNA fragments that overlapped each other for assembling the complete genome sequence of XJ-04 except the 5'-and 3'-ends.
To determine the 5'-and 3'-ends with the method of RNA ligation and PCR, a pair of primers was designed based on the known partial sequence near the 5'-and 3'-ends (Table 1) .
Viral RNA was extracted from the supernatant of virus stocks using Trizol LS Reagent (Invitrogen) following the manufacturer's instructions. Isolated RNA was dissolved in RNase-free water and applied as template for the synthesis of the first strand cDNA. The RT step was carried out using the PrimeScriptTM 1st strand cDNA Synthesis Kit (TaKaRa) according to the manufacturer's instructions. 17 overlapping cDNA fragments were further amplified by PCR using Taq DNA polymerase (New England Biolabs) and appropriate primers (Table 1) . PCR products were purified using the TIANgel Midi Purification Kit (Tiangen) and ligated into pMD-19 simple T vector (TaKaRa) according to the manufacturer's specifications and then transformed into Escherichia coli DH5α by a standard procedure. To obtain a precise sequence for each amplified region, 3 recombinant clones derived from 3 independent PCRs were selected for sequencing by commercial service (Shanghai Sangon Biological Engineering Technology & Services).
For precise determination of the 5'-and 3'-end sequences, the RNA ligation method was utilized prior to the first cDNA synthesis as described previously Becher et al., 1998) with some modification. For this analysis, genomic RNA was prepared using the QIAamp Viral RNA Mini Kit (Qiagen) following the manufacturer's instructions. RNA (2 µg) was self-ligated via its 5'-and 3'-end using 120 U of T4 RNA ligase (New England Biolabs) in a 60 µl reaction mixture containing 50 mmol/l Tris-HCl (pH 7.8), 10 mmol/l MgCl 2 , 10 mmol/l dithiothreitol, 1 mmol/l ATP, and 120 U RNasin (Promega) for 5 hrs at 37°C. After phenolchloroform extraction and ethanol precipitation, the pellet was resuspended in 10 µl of RNase-free water. 3 µl of the solution were used as the template for amplification of the junction region of the 5'-3' self-ligated genomic RNA. Then six 5'-3'ligation clones were subjected to sequencing. In total, 18 overlapping fragments covering the complete genome of XJ-04 were available ranging from 282 to 1,576 bp in size. All the nucleotide sequences were manually proof-read with the help of biosoftware DNASTAR (Dnastar) and assembled into consecutive sequence. Thus, the complete genome 12,284 nt long was generated containing a large ORF of 11,694 nt flanked with 5'-UTR of 385 nt and 3'-NCR of 205 nt. The ORF encoded a single polyprotein of 3,897 aa with the relative molecular mass M r = 438.3 K. The genomic organization of isolate XJ-04 is consistent with that of other BVDV viruses (Collet et al., 1988; Deng and Brock 1992; Rümenapf et al., 1993; Ridpath and Bolin 1995; Xu et al., 2006; Novácková et al., 2008) . Based on the putative processing sites, the structure of the entire XJ-04 genome from 5'-UTR to 3'-NCR including nucleotide positions was as follows: The ORF encoded a single polyprotein of 3,897 aa with M r of 438.3 K. Amino acid sequence comparison analysis showed that the point mutations are mainly distributed in the structural protein E rns , E1, and E2 (data not shown). The polyprotein contained 20 potential N-glycosylation sites (Asn-X-Ser or Asn-X-Thr). Among those 14 glycosylation sites were located in the structural proteins E rns , E1, and E2.
Compared with strains 890 (BVDV-2) and SD-1 (BVDV-1), the isolate XJ-04 contained similar predicted glycosylation sites except variations at three positions, i.e. deletion sites at aa 272 in E rns , aa 516 in E1 and one additional site at aa 951 in E2, respectively (Table 2) .
For typing of the isolate XJ-04, 243 bp (genome position of 129-371 nt in the strain 890) of the sequences within 5'-UTR regions and the complete genomic sequences were used to perform a phylogenetic analysis. The sequences were processed with Bioedit software and used to generate the phylogenetic tree by biosofteware MEGA 4.1 using the neighbor-joining method (Hall, 1999; Kumar et al., 2008) . Bootstrap probabilities were calculated with 1000 replicates. The phylogram constructed with complete genome sequences revealed that the isolate XJ-04 belonged to BVDV-2 (Fig. 1a) . Furthermore, a tree constructed with the regions of 5'-UTR grouped the isolate into the branch of BVDV-2a (Fig. 1b) . The region coding for viral autoprotease N pro gene is also usually used for virus typing. Comparative analysis of the N pro gene showed that nt and aa identity values were also closer to BVDV-2 reference strain 890 (87.8% and 98.4 %, respectively) than to BVDV-1 reference strain NADL (67.1% and 94.8%, respectively). Additionally, this classification was supported by the nt identity analysis of the complete genome. The genomic similarity to the strain 890 was 90.1%, but to the strain NADL was only 68.0%.
For further characterization of XJ-04, the nt and aa identity analysis in the structural proteins C, E rns , E1 and E2 between XJ-04 and BVDV reference strains was performed. The identity shared by XJ-04 with strains 890 and The discrepancy of low identity at nt level and high identity at aa level suggested that many synonymous codons were employed. Table 2 also showed that E2 gene in XJ-04 coding for the most immunogenic protein was poorly homologous to NADL, what was in accord with the fact that low serological cross-reactivity was observed between these two viruses (unpublished data). BVDV of cytopathic (cpBVDV) and non-cytopathic type are distinguished by their effect on the cell culture (McClurkin et al., 1985; Baker, 1987) . Cytopathic type of BVDV is correlated with the presence of insertions of cellular sequences, duplication of viral sequences with or without insertions, deletions, and point mutations in the genomes (Baroth et al., 2000; Becher et al., 2002; Quadros et al., 2006) . Reported insertions in cpBVDV are distributed mainly at three positions including aa 1161, aa 1545, and aa 1589 at the area of NS2/3 genes (Ridpath et al., 2006) . Also, insertions outside of the NS2 /3 genes in BVDV strain CP8 were reported (Müller et al., 2003) . However, alignment of the entire genomic sequence for XJ-04 and other BVDV isolates available in GenBank showed that no insertion existed within or outside of NS2/3 gene in the isolate XJ-04 (data not shown). Similarly, cpBVDV-1 Oregon C24V does not contain any insertions and a relation between point mutations in the NS2 region and the cytopathic type of this virus has been confirmed (Kümmerer et al., 1998) . Definitely, a reason for the cytopathic phenotype of isolate XJ-04 needs further study. To our knowledge a BVDV-2 strain with cytopathic phenotype and without insertions has not been reported yet.
In this report, we described the first complete genome sequence of BVDV-2 isolate XJ-04 originated from China. The phylogenetic analysis revealed that XJ-04 was located in the branch of BVDV-2 and can be further subtyped as BVDV-2a. This classification was supported by similarity of XJ-04 to BVDV-2 reference strain 890 at both nt and aa level in the structural genes and N pro gene. In spite of the fact that isolate XJ-04 displayed a cytophatic phenotype, we found no insertion in its genome. The presented data supplement the general knowledge about the BVDV genomics and provide further information about the pestivirus genetic diversity in China. Roman script and italic script represent the nucleotide and amino acid sequence identities, respectively. The scale indicates the number of substitutions per site. Sequences of individual strains are available in GenBank.
NADL varied from 90.8% to 92.7% and from 65.1% to 80.0% at nt level, respectively. However, at aa level XJ-04 shared high similarity to both 890 and NADL in the range of 97.3%-99.3% and 88.7%-96.9%, respectively (Table 3 ).
